We aim to test how inhibitory processes within the primary motor cortex change over time during the resolution of response conflict.
ID
Source
Brief title
Condition
- Other condition
Synonym
Health condition
neuroscientific research
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
Changes in the amplitude of the MEP in response to single- and paired-pulse TMS
(sICI) as a function of task condition (left or right hand response, conflict
or no conflict trial).
Secondary outcome
behavioral outcome of choice RT task.
Background summary
In daily life, we often need to deal with situations in which a number of
actions are potentially possible and are in conflict with each other,
situations of so-called *response conflict*. Our brain needs to select the best
of these competing responses and suppress unwanted actions. There is a
substantial literature regarding which higher-level areas of the human brain
assist in this process of response selection. However, it remains unknown how
and by which physiological mechanism these areas affect the *output station* of
the brain, the primary motor cortex. A potential mechanism is the involvement
of inhibitory interneurons, which can be directly tested using transcranial
magnetic stimulation (TMS).
Study objective
We aim to test how inhibitory processes within the primary motor cortex change
over time during the resolution of response conflict.
Study design
In order to probe inhibitory processes within the primary motor cortex, this
study will employ single- and paired-pulse TMS. A TMS coil will be positioned
over the primary motor cortex of the left hemisphere. The dependent measure in
the task is the change across single- and paired-pulse trials in the amplitude
of the motor-evoked potential (MEP). This change in amplitude is termed short
intra-cortical inhibition* or sICI. The MEP is elicited by the TMS in the
muscle of one of the response hands. The TMS will be applied while participants
are performing a simple choice reaction time task. The stimuli are arranged
such that they elicit only one response (no conflict) or two competing
responses of which only one is correct (conflict). Four different time points
will be used for stimulation with one time point per trial. In this way the
individual time specific physiological pattern of inhibitory processes can be
identified for either conflict or no conflict situation
Intervention
Participants will receive a total of 864 trials. On half of the trials a single
pulse of TMS will be applied, on the other half of trials two TMS pulses will
be applied in quick succession.
Study burden and risks
Participants will not directly benefit from their participation in the study.
Transcranial magnetic stimulation (TMS) is a widely used non-invasive brain
stimulation technique, based on the principle of electromagnetic induction.
During stimulation the participant will likely hear the clicks of the TMS
pulses and experience a slight stimulation of nerves and muscles of the head.
The most common side effect is a light transient headache (2-4% occurrence). A
severe headache is uncommon (0.3-0.5% occurrence). In TMS studies using certain
patient populations (e.g. epilepsy) or that exceeded the standard protocols
(e.g. in intensity or frequency) epileptic seizures have been reported in rare
cases. In the current study healthy participants will be stimulated with a
protocol that falls within the safety guidelines. All subjects are screened for
their relevant medical history and other TMS safety aspects (e.g. presence of
metal parts in the head). In summary, because the risk and burden associated
with participation can be considered negligible-to-minimal, we do not expect
serious adverse events during the project.
Kapittelweg 29
Nijmegen 6525 EN
NL
Kapittelweg 29
Nijmegen 6525 EN
NL
Listed location countries
Age
Inclusion criteria
Only healthy, competent, right-handed participants, 18-45 years old, with normal vision or corrected-to normal
vision by means of contact lenses.
Exclusion criteria
Serious head trauma or brain surgery
- Large or ferromagnetic metal parts in the head (except for a dental wire)
- Implanted cardiac pacemaker or neurostimulator
- Pregnancy
- Large of ferromagnetic metal parts in the body
- Claustrophobia
- Skin diseases at intended electrode sites
- Disorders of vision (i.e., deviation from *normal or corrected-to-normal vision*)
- History or current presence of any neurologic or psychiatric disease
- Any prescribed medication that can alter cortical excitability (e.g. antiepileptics, tricyclic anti-depressives or benzodiazepines) or can have an influence on the participant*s vigilance or cognitive performance within two weeks prior to participation.
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL48749.091.14 |